Frequency of prolonged remission duration after high-dose cytarabine intensification in acute myeloid leukemia varies by cytogenetic subtype.
Cancer Res
; 58(18): 4173-9, 1998 Sep 15.
Article
en En
| MEDLINE
| ID: mdl-9751631
Buscar en Google
Banco de datos:
MEDLINE
Asunto principal:
Leucemia Mieloide
/
Citarabina
/
Antimetabolitos Antineoplásicos
Tipo de estudio:
Clinical_trials
/
Etiology_studies
/
Incidence_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Límite:
Adolescent
/
Adult
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Año:
1998
Tipo del documento:
Article